Natera, Inc. (NTRA)

231.95 +0.90 (+0.39%) USD  |  NASDAQ  |  Dec 12, 16:00
231.75 -0.20 (-0.09%) After-Hours: 20:00
More

Natera Research and Development Expense (Quarterly): 173.41M for Sept. 30, 2025

Research and Development Expense (Quarterly) Chart

View Research and Development Expense (Quarterly) for NTRA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
EXACT Sciences Corp. 117.22M
Illumina, Inc. 228.00M
Mettler-Toledo International, Inc. 51.14M
Guardant Health, Inc. 89.96M
Delcath Systems, Inc. 7.986M